Collegium Pharmaceutical, Inc. (NASDAQ:COLL) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| John G. Freund Other companies: SI-BONE, Inc. (Director · Since at least Oct 16, 2018); Sutro Biopharma, Inc. (Director · Sep 26, 2018 – Jun 6, 2024 · Past); Protara Therapeutics, Inc. (Director · Oct 21, 2014 – Nov 8, 2019 · Past); Concert Pharmaceuticals Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Tetraphase Pharmaceuticals Inc (Director · Mar 19, 2013 – Dec 10, 2019 · Past); Sirtris Pharmaceuticals Inc (Director · May 22, 2007 – May 29, 2007 · Past); Hansen Medical Inc (Director · Nov 15, 2006 – Jun 17, 2009 · Past); XenoPort Inc (Director · May 2, 2006 – Jul 5, 2016 · Past) | Director · Since at least May 6, 2015 |
| Theodore R Schroeder Other companies: Phathom Pharmaceuticals, Inc. (Director · Since at least Apr 16, 2025); Cidara Therapeutics Inc (Director · Since at least Apr 14, 2015); Nabriva Therapeutics AG (Director · Jul 24, 2018 – Jan 29, 2023 · Past); Otonomy Inc (Director · Aug 28, 2015 – Jun 21, 2022 · Past); Hyperion Therapeutics Inc (Director · Aug 11, 2014 – May 7, 2015 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (President, CEO, Director · Oct 24, 2006 – Mar 19, 2014 · Past) | Director · Jan 22, 2016 – May 20, 2020 · Past |
| Gino Santini Other companies: COMPASS Pathways Plc (CHAIRMAN OF THE BOARD · Since at least Sep 3, 2024); Allena Pharmaceuticals Inc (Director · Nov 1, 2017 – Jun 3, 2021 · Past); Vitae Pharmaceuticals Inc (Director · May 26, 2016 – Oct 25, 2016 · Past); AMAG Pharmaceuticals Inc (Director · May 19, 2016 – Nov 16, 2020 · Past); Horizon Pharma PLC (Director · May 3, 2016 – May 3, 2018 · Past); Intercept Pharmaceuticals Inc (Director · Nov 24, 2015 – Nov 8, 2023 · Past) | Chairman of the Board · Since at least Sep 10, 2015 |
| Carlos Paya Other companies: Vaxcyte, Inc. (President, Immune Design Corp Chairman, Vaxcyte · Since at least Oct 27, 2021); Mallinckrodt Inc (Director · May 22, 2019 – Jun 16, 2022 · Past); Standard BioTools Inc. (Director · Mar 23, 2017 – Jun 14, 2023 · Past); Immune Design Corp (President and CEO, Director · Oct 30, 2015 – Apr 2, 2019 · Past) | Director · Since at least May 15, 2025 |
| David Hirsch Other companies: Rapid Micro Biosystems, Inc. (Director · Jul 14, 2021 – May 23, 2024 · Past); Poseida Therapeutics Inc (Director · Jul 9, 2020 – Jul 23, 2021 · Past); Tricida Inc (Director · Jun 27, 2018 – Jun 15, 2022 · Past); Molecular Templates Inc (Director · Aug 1, 2017 – Jun 3, 2022 · Past) | Director · May 6, 2015 – May 20, 2020 · Past |
| Garen Bohlin Other companies: Karyopharm Therapeutics Inc. (Director · Since at least Jun 16, 2016); Protara Therapeutics, Inc. (Director · Jun 9, 2016 – Jun 8, 2018 · Past); Tetraphase Pharmaceuticals Inc (Director · Jun 8, 2016 – Jun 10, 2019 · Past) | Director · Since at least Jun 9, 2016 |
| John A Fallon Other companies: EXACT Sciences Corporation (Director · Jan 25, 2016 – Jul 30, 2018 · Past); AMAG Pharmaceuticals Inc (Director · Sep 5, 2014 – Nov 16, 2020 · Past); Insulet Corporation (Director · Oct 24, 2012 – May 21, 2021 · Past) | Director · Since at least Jun 9, 2016 |
| Nancy S. Lurker Other companies: Alkermes plc (Director · Since at least Mar 5, 2024); EyePoint, Inc. (Director · Since at least Mar 29, 2019); Aquestive Therapeutics, Inc. (Director · Jun 13, 2019 – Jun 15, 2021 · Past) | Director · Since at least Feb 4, 2025 |
| Douglas R Carlson Other companies: Avalyn Pharma Inc. (See Remarks · Since at least Apr 29, 2026); ImageneBio, Inc. (COO & EVP of Finance · Mar 25, 2021 – Mar 25, 2021 · Past) | VP Corp. Devlp · May 6, 2015 – May 6, 2015 · Past |
| Paul Brannelly Other companies: Karyopharm Therapeutics Inc. (SVP, FINANCE & ADMIN, TREAS · Nov 5, 2013 – May 15, 2014 · Past) | Executive Vice President & CFO · May 6, 2015 – Feb 10, 2021 · Past |
| Richard Malamut Other companies: Pelthos Therapeutics Inc. (Director · Since at least Feb 15, 2024) | EVP and Chief Medical Officer · Apr 1, 2019 – Feb 10, 2022 · Past |
| Vikram Karnani Other companies: Dyne Therapeutics, Inc. (Board Member · Since at least Dec 22, 2025) | PRESIDENT & CHIEF EXECUTIVE OFFICER · Since at least Nov 7, 2024 |
| Alison B Fleming | EVP & Chief Technical Officer · Jan 4, 2017 – Aug 10, 2021 · Past |
| Arun Padmanabhan | General Manager, Pain · Since at least Nov 5, 2026 |
| Barry S Duke | See remarks · May 6, 2015 – Mar 17, 2017 · Past |
| Colleen Tupper | Executive Vice President, Chief Financial Officer · Since at least May 24, 2021 |
| Danielle Jesse | Director, Investor Relations · Oct 29, 2025 – Nov 5, 2026 · Past |
| David Dieter | EVP & General Counsel · Since at least Mar 17, 2025 |
| Dean J. Patras | Chief People Officer · Since at least May 8, 2025 |
| Donovan Michael Glancy | Director · Since at least May 14, 2026 |
| Ian Karp | Vice President, Investor Relations · Oct 29, 2025 – Nov 5, 2026 · Past |
| Ingrid McPhilliamy | General Manager, ADHD · Since at least Oct 6, 2026 |
| Jane Gonnerman | Executive Vice President, Strategy & Corporate Development · Since at least May 8, 2025 |
| Jessica Cotrone | Senior Vice President, Corporate Communications & Corporate Affairs · Since at least Nov 5, 2026 |
| Jessica Cotrone Senior | Vice President, Corporate Communications & Corporate Affairs · Since at least Oct 21, 2026 |
| Michael G. Donovan | Director · Since at least Aug 6, 2026 |
| Rita Balice-Gordon | Director · Since at least Sep 24, 2020 |
| Scott Dreyer | EVP & Chief Commercial Officer · Since at least Jul 10, 2019 |
| Scott Sudduth | Executive Vice President, Head of Technical Operations · Since at least Nov 5, 2026 |
| Shirley R Kuhlmann | EVP and General Counsel · Nov 27, 2023 – Mar 4, 2025 · Past |
| Thomas Smith | EVP and Chief Medical Officer · Since at least Feb 12, 2024 |